Publication Date
| In 2024 | 0 |
| Since 2023 | 0 |
| Since 2020 (last 5 years) | 0 |
| Since 2015 (last 10 years) | 0 |
| Since 2005 (last 20 years) | 1 |
Descriptor
| Cancer | 1 |
| Case Studies | 1 |
| Evidence | 1 |
| Foreign Countries | 1 |
| Policy Formation | 1 |
| Randomized Controlled Trials | 1 |
| Screening Tests | 1 |
Author
| Carter, Stacy M. | 1 |
| Flitcroft, Kathy L. | 1 |
| Gillespie, James A. | 1 |
| Salkeld, Glenn P. | 1 |
| Trevena, Lyndal J. | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
| Australia | 1 |
| New Zealand | 1 |
| United Kingdom | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkFlitcroft, Kathy L.; Gillespie, James A.; Carter, Stacy M.; Trevena, Lyndal J.; Salkeld, Glenn P. – Evidence & Policy: A Journal of Research, Debate and Practice, 2011
Bowel cancer is a serious health problem in developed countries. Australia, the United Kingdom (UK) and New Zealand (NZ) reviewed the same randomised controlled trial evidence on the benefits and harms of population-based bowel cancer screening. Yet only NZ, with the highest age standardised rate of bowel cancer mortality, decided against…
Descriptors: Cancer, Screening Tests, Foreign Countries, Randomized Controlled Trials
